Daiken Biomedical Co., Ltd. (TPE:7780)
Taiwan · Delayed Price · Currency is TWD 18.25
+0.05 (0.27%)
At close: Jun 24, 2026
Daiken Biomedical Market Cap
Daiken Biomedical has a market cap or net worth of 14.78 billion as of June 25, 2026. Its market cap has increased by 53.03% in one year.
Market Cap
14.78B
Enterprise Value
9.47B
Revenue
2.02B
Ranking
n/a
PE Ratio
38.96
Stock Price
18.25
Market Cap Chart
Since October 28, 2024, Daiken Biomedical's market cap has increased from 10.68B to 14.78B, an increase of 38.41%. That is a compound annual growth rate of 21.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 14.78B | 1.67% |
| Dec 31, 2025 | 14.54B | 33.88% |
| Dec 31, 2024 | 10.86B | 1.69% |
| Oct 28, 2024 | 10.68B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Charoen Pokphand Enterprise (Taiwan) | 33.90B |
| Standard Foods | 26.39B |
| Lian Hwa Foods | 26.26B |
| TTET Union | 22.80B |
| Ve Wong | 10.33B |
| Tehmag Foods | 9.93B |
| Microbio | 8.91B |
| Taisun Enterprise | 8.73B |